Massive opportunity.
This blip affects a drop in their customer bucket. Scott Phillips of Motley Fool waxing lyrical on Sky Business tonight, he has a screaming buy on it.
Arguments in favour;
1) US population fighting obesity in significant numbers
2) An ageing Australian and Chinese population
3) No competition for RMD product range (SOM and Co have very different products).
It affects 2% of their current revenue/customer base, the market share going forward is expanding exponentially.
Where does this end?, page-39
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
